Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases

Biomaterials

Volumn 35, Issue 16, 2014, Pages 4688-4698

  Tseng, Yu Cheng ^a   Xu, Zhenghong ^a   Guley, Kevin ^a   Yuan, Hong ^a   Huang, Leaf ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

LCP; Lymph node; Lymphotropism; Metastasis; Nanoparticle; SPECT

Indexed keywords

DRUG DELIVERY; GENE TRANSFER; NANOPARTICLES; PATHOLOGY;

LCP; LYMPH NODE; LYMPHOTROPISM; METASTASIS; SPECT;

BODY FLUIDS;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CALCIUM PHOSPHATE; COMPLEMENTARY DNA; DIOLEOYLPHOSPHATIDIC ACID; DIOLEOYLPHOSPHATIDYLCHOLINE; INDIUM 111; LIPID CALCIUM PHOSPHATE NANOPARTICLE; MACROGOL; NANOPARTICLE; RED FLUORESCENT PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; COMPUTER ASSISTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; LIPID BILAYER; LIPID MEMBRANE; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURFACE CHARGE; SURFACE PROPERTY; ZETA POTENTIAL;

MUS MUSCULUS;

LCP; LYMPH NODE; LYMPHOTROPISM; METASTASIS; NANOPARTICLE; SPECT;

ANIMALS; CALCIUM PHOSPHATES; FEMALE; INDIUM RADIOISOTOPES; LIPIDS; LYMPH NODES; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; NANOPARTICLES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84896547201     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.02.030     Document Type: Article

References (49)

1. Xie Y., Bagby T.R., Cohen M.S., Forrest M.L. Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies. Expert Opin Drug Deliv 2009, 6:785-792.
2. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-572.
3. Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nat Rev Cancer 2004, 4:448-456.
4. Sleeman J.P. The relationship between tumors and the lymphatics: what more is there to know?. Lymphology 2006, 39:62-68.
5. Porter C.J. Drug delivery to the lymphatic system. Crit Rev Ther Drug Carrier Syst 1997, 14:333-393.
6. Reddy L.H., Murthy R.S. Pharmacokinetics and biodistribution studies of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2004, 148:161-166.
7. Kaminskas L.M., Porter C.J. Targeting the lymphatics using dendritic polymers (dendrimers). Adv Drug Deliv Rev 2011, 63:890-900.
8. Cai S., Yang Q., Bagby T.R., Forrest M.L. Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Adv Drug Deliv Rev 2011, 63:901-908.
9. Erogbogbo F., Yong K.T., Roy I., Hu R., Law W.C., Zhao W., et al. Invivo targeted cancer imaging, sentinel lymph node mapping and multi-channel imaging with biocompatible silicon nanocrystals. ACS Nano 2011, 5:413-423.
10. Tang L., Yang X., Dobrucki L.W., Chaudhury I., Yin Q., Yao C., et al. Aptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymph nodes with metastatic tumors. Angew Chem Int Ed Engl 2012, 51:12721-12726.
11. Psimadas D., Georgoulias P., Valotassiou V., Loudos G. Molecular nanomedicine towards cancer: (111) In-labeled nanoparticles. JPharm Sci 2012, 101:2271-2280.
12. Kelkar S.S., Reineke T.M. Theranostics: combining imaging and therapy. Bioconjug Chem 2011, 22:1879-1903.
13. Doane T.L., Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev 2012, 41:2885-2911.
14. Nam J., Won N., Bang J., Jin H., Park J., Jung S., et al. Surface engineering of inorganic nanoparticles for imaging and therapy. Adv Drug Deliv Rev 2012, 65:622-648.
15. Li J., Yang Y., Huang L. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. JControl Release 2012, 158:108-114.
16. Yang Y., Hu Y., Wang Y., Li J., Liu F., Huang L. Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung caner. Mol Pharm 2012, 9:2280-2289.
17. Yang Y., Li J., Liu F., Huang L. Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis. Mol Ther 2012, 20:609-615.
18. Hu Y., Haynes M.T., Wang Y., Liu F., Huang L. Ahighly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei invivo. ACS Nano 2013, 7:5376-5384.
19. Almeida J.P., Chen A.L., Foster A., Drezek R. Invivo biodistribution of nanoparticles. Nanomedicine (Lond) 2011, 6:815-835.
20. Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., van de Kaa C.H., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. NEngl J Med 2003, 348:2491-2499.
21. Harisinghani M.G., Saksena M.A., Hahn P.F., King B., Kim J., Torabi M.T., et al. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?. AJR Am J Roentgenol 2006, 186:144-148.
22. Nakai G., Matsuki M., Harada T., Tanigawa N., Yamada T., Barentsz J., et al. Evaluation of axillary lymph nodes by diffusion-weighted MRI using ultrasmall superparamagnetic iron oxide in patients with breast cancer: initial clinical experience. JMagn Reson Imaging 2011, 34:557-562.
23. Xiong L., Shuhendler A.J., Rao J. Self-luminescing BRET-FRET near-infrared dots for invivo lymph-node mapping and tumour imaging. Nat Commun 2012, 3:1193.
24. Dong H., Dube N., Shu J.Y., Seo J.W., Mahakian L.M., Ferrara K.W., et al. Long-circulating 15 nm micelles based on amphiphilic 3-helix peptide-PEG conjugates. ACS Nano 2012, 6:5320-5329.
25. Wang Y., Liu Y., Luehmann H., Xia X., Brown P., Jarreau C., et al. Evaluating the pharmacokinetics and invivo cancer targeting capability of au nanocages by positron emission tomography imaging. ACS Nano 2012, 6:5880-5888.
26. Graham M.J., Freier S.M., Crooke R.M., Ecker D.J., Maslova R.N., Lesnik E.A. Tritium labeling of antisense oligonucleotides by exchange with tritiated water. Nucleic Acids Res 1993, 21:3737-3743.
27. Zhang G., Yang Z., Lu W., Zhang R., Huang Q., Tian M., et al. Influence of anchoring ligands and particle size on the colloidal stability and invivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 2009, 30:1928-1936.
28. Tammela T., Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010, 140:460-476.
29. Huang X., Zhang F., Lee S., Swierczewska M., Kiesewetter D.O., Lang L., et al. Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. Biomaterials 2012, 33:4370-4378.
30. Li S.D., Chono S., Huang L. Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles. JControl Release 2008, 126:77-84.
31. Mou Y., Hou Y., Chen B., Hua Z., Zhang Y., Xie H., et al. Invivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide. Int J Nanomedicine 2011, 6:2633-2640.
32. Zhang F., Zhu L., Huang X., Niu G., Chen X. Differentiation of reactive and tumor metastatic lymph nodes with diffusion-weighted and SPIO-enhanced MRI. Mol Imaging Biol 2012, 15:40-47.
33. Romberg B., Hennink W.E., Storm G. Sheddable coatings for long-circulating nanoparticles. Pharm Res 2008, 25:55-71.
34. Li S.D., Huang L. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. JControl Release 2010, 145:178-181.
35. Tseng Y.C., Mozumdar S., Huang L. Lipid-based systemic delivery of siRNA. Adv Drug Deliv Rev 2009, 61:721-731.
36. Keidar Z., Israel O., Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med 2003, 33:205-218.
37. Kim W., Menda Y., Willis J., Bartel T.B., Graham M.M. Use of lymphoscintigraphy with SPECT/CT for sentinel node localization in a case of vaginal melanoma. Clin Nucl Med 2006, 31:201-202.
38. Ishihara T., Kaguchi A., Matsushita S., Shiraishi S., Tomiguchi S., Yamashita Y., et al. Management of sentinel lymph nodes in malignant skin tumors using dynamic lymphoscintigraphy and the single-photon-emission computed tomography/computed tomography combined system. Int J Clin Oncol 2006, 11:214-220.
39. Khafif A., Schneebaum S., Fliss D.M., Lerman H., Metser U., Ben-Yosef R., et al. Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinoma. Head Neck 2006, 28:874-879.
40. Even-Sapir E., Lerman H., Lievshitz G., Khafif A., Fliss D.M., Schwartz A., et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. JNucl Med 2003, 44:1413-1420.
41. Kizu H., Takayama T., Fukuda M., Egawa M., Tsushima H., Yamada M., et al. Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients. JNucl Med Technol 2005, 33:78-82.
42. Sherif A., Garske U., de la Torre M., Thorn M. Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 2006, 50:83-91.
43. Cavert W., Notermans D.W., Staskus K., Wietgrefe S.W., Zupancic M., Gebhard K., et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997, 276:960-964.
44. Desormeaux A., Bergeron M.G. Lymphoid tissue targeting of anti-HIV drugs using liposomes. Methods Enzymol 2005, 391:330-351.
45. Kinman L., Brodie S.J., Tsai C.C., Bui T., Larsen K., Schmidt A., et al. Lipid-drug association enhanced HIV-1 protease inhibitor indinavir localization in lymphoid tissues and viral load reduction: a proof of concept study in HIV-2287-infected macaques. JAcquir Immune Defic Syndr 2003, 34:387-397.
46. Gagne J.F., Desormeaux A., Perron S., Tremblay M.J., Bergeron M.G. Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes. Biochim Biophys Acta 2002, 1558:198-210.
47. Kinman L., Bui T., Larsen K., Tsai C.C., Anderson D., Morton W.R., et al. Optimization of lipid-indinavir complexes for localization in lymphoid tissues of HIV-infected macaques. JAcquir Immune Defic Syndr 2006, 42:155-161.
48. Zhang Y., Schwerbrock N.M., Rogers A.B., Kim W.Y., Huang L. Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC. Mol Ther 2013, 21:1559-1569.
49. Endsley A.N., Ho R.J. Enhanced anti-HIV efficacy of indinavir after inclusion in CD4 targeted lipid nanoparticles. JAcquir Immune Defic Syndr 2012, 61:417-424.